| Literature DB >> 34056238 |
Tushar M Khopade1, Kalyani Ajayan1, Swapnil S Joshi1, Amy L Lane2, Rajesh Viswanathan1,2.
Abstract
Tryptophan-containing isoprenoid indole alkaloid natural products are well known for their intricate structural architectures and significant biological activities. Nature employs dimethylallyl tryptophan synthases (DMATSs) or aromatic indole prenyltransferases (iPTs) to catalyze regio- and stereoselective prenylation of l-Trp. Regioselective synthetic routes that isoprenylate cyclo-Trp-Trp in a 2,5-diketopiperazine (DKP) core, in a desymmetrizing manner, are nonexistent and are highly desirable. Herein, we present an elaborate report on Brønsted acid-promoted regioselective tryptophan isoprenylation strategy, applicable to both the monomeric amino acid and its dimeric l-Trp DKP. This report outlines a method that regio- and stereoselectively increases sp3 centers of a privileged bioactive core. We report on conditions involving screening of Brønsted acids, their conjugate base as salt, solvent, temperature, and various substrates with diverse side chains. Furthermore, we extensively delineate effects on regio- and stereoselection of isoprenylation and their stereochemical confirmation via NMR experiments. Regioselectively, the C3-position undergoes normal-isoprenylation or benzylation and forms exo-ring-fused pyrroloindolines selectively. Through appropriate prenyl group migrations, we report access to the bioactive tryprostatin alkaloids, and by C3-normal-farnesylation, we access anticancer drimentines as direct targets of this method. The optimized strategy affords iso-tryprostatin B-type products and predrimentine C with 58 and 55% yields, respectively. The current work has several similarities to biosynthesis, such as-reactions can be performed on unprotected substrates, conditions that enable Brønsted acid promotion, and they are easy to perform under ambient conditions, without the need for stoichiometric levels of any transition metal or expensive ligands.Entities:
Year: 2021 PMID: 34056238 PMCID: PMC8153798 DOI: 10.1021/acsomega.1c00515
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1(A) Biosynthesis of isoprenylated tryptophan alkaloids by DMATS or PTs. PPi = inorganic diphosphate; l-Trp = l-tryptophan; AA = amino acid other than l-Trp; DKP = 2,5-diketopiperazine. Isoprenylation pattern shown in (A) is generic and enzyme products with each of the seven positions undergoing prenyation are known. (B) Representative isoprenylated tryptophan natural products are presented with the Trp core shown in red and isoprenyl chains in blue. Sites of isoprenylation are shown in circle. Respective medicinal activities of these members underscore the significance of synthetic methods affording scalable access to their structures.
Figure 2(A) Summary of Ishikawa’s study (ref (10)) reported biomimetic prenylation reaction resulting in poor regioselectivity. (B) Current work: As an elaboration of previous report (ref (9b)), an expanded scope and utility of this regioselective method is presented.
a
| S. No | solvent(s) | salt | % yield | |
|---|---|---|---|---|
| 1 | AcOH/H2O (1:5) | NaOAc | RT, 24 (h) | 30% total yield |
| 2 | AcOH/H2O/MeOH (1:5:1) | NaOAc | RT, 24 (h) | 23% total yield |
| 3 | AcOH | NaOAc | RT, 24 (h) | 70% C3-prenylation, 6% C2-prenylation |
| 4 | EtOAc/MeOH (1:1) | NaOAc | RT, 24 (h) | 69% |
| 5 | ACN/MeOH (1:1) | NaOAc | RT, 24 (h) | 65% |
| 6 | MeOH | RT, 24 (h) | 70% | |
| 7 | DMSO | 50 °C, 5 (h) | no reaction |
Reaction conditions: -Trp-OMe (100 mg, 0.458 mmol, 1.0 equiv), prenyl bromide (10) (105 μL, 0.92 mmol, 2 equiv) in various solvents.
Reaction performed in 0.1 M solvent(s).
2.0 equiv of salt added.
Products isolated after purification by column chromatography: C3/C2/N-prenylation determined by NMR analyses.
a
| S. no | salt | Brønsted acid promoter | solvent | total yield
(%) (C2 yield) | dr | |
|---|---|---|---|---|---|---|
| 1 | NaOAc | AcOH | AcOH | RT | 50 (6) | 1:1 |
| 2 | NaOAc | AcOH | AcOH/MeOH (9:1) | RT | 47 (11) | |
| 3 | LiOAc | AcOH | AcOH | RT | 76 (9) | 1:1 |
| 4 | CsOAc | AcOH | AcOH | RT | 55 (6) | 1:1 |
| 5 | KOAc | AcOH | AcOH | RT | 55 (6) | 1:1 |
| 6 | AgOAc | AcOH | AcOH | RT | 25 (nd) | nd |
| 7 | AgOAc | AcOH | AcOH | RT | Decomp. | |
| 8 | LiOAc | ( | AcOH | RT | 70 (8) | 1:1 |
| 9 | LiOAc | ( | AcOH | RT | 70 (8) | 1:1 |
| 10 | LiOAc | ( | AcOH | RT | 65 (8) | 1:1 |
| 11 | LiOAc | ( | AcOH | RT | 65 (8) | 1:1 |
Reaction conditions: l-Trp-methyl ester (-Trp-OMe) (220 mg, 0.916 mmol, 1.0 equiv), prenyl bromide (10) (212 μL, 1.83 mmol, 2.0 equiv) in acetic acid (0.1 M), 12 h.
2.0 equiv of salt added.
1.0 equiv of the Brønsted acid promoter added.
Isolated yield after purification by column chromatography and calculated based on recovered starting material: C3/C2-prenylation determined by NMR analyses.
dr-diastereomeric ratio between exo and endo isomers (by NMR). RT: room temperature; Decomp: substrates decomposed into unverifiable mixture; nd-not determined. Method is scaled up to 0.5 g of -Trp-OMe, and no reduction in the isolated yield was observed.
a
Reaction conditions: l-Trp-methyl ester (-Trp-OMe) (200 mg, 0.916 mmol, 1.0 equiv), bromide (10, 14, 17–20) (1.84 mmol, 2 equiv) in acetic acid (0.1 M).
Isolated yield after purification by column chromatography; yield calculated based on the recovered starting material: C3 and C2-functionalistaion determined by NMR analyses.
dr-diastereomeric ratio between exo and endo isomers—calculated based on isolated yield and NMR analysis.
Scheme 1Synthesis of -Trp--Trp DKP
a
| S. no | salt | solvent | time (h) | total yield | dr |
|---|---|---|---|---|---|
| 1 | AcOH | 12 | 30 | nd | |
| 2 | NaOAc | AcOH | 12 | 54 | 3:1 |
| 3 | LiOAc | AcOH | 12 | 48 | 3:1 |
| 4 | CsOAc | AcOH | 12 | 45 | 3:1 |
| 5 | LiBr | AcOH | 12 | 40 | 3:1 |
| 6 | AcOH | 12 | 35 | nd | |
| 7 | AcOH | 12 | decomp. | ||
| 8 | DABCO | AcOH | 24 | 40 | 3:1 |
| 9 | quinine | AcOH | 24 | 38 | nd |
| 10 | NaOAc | DMSO | 24 | trace | |
| 11 | NaOAc | DMF | 24 | trace | |
| 12 | NaOAc | MeOH/EtOAc (1:1) | 48 | nd | |
| 13 | NaOAc | MeOH/ACN (1:1) | 48 | nd |
Reaction conditions: -Trp--Trp DKP (100 mg, 268.51 μmol, 1.0 equiv), 10 (62 μL, 537.02 μmol, 2.0 equiv) in solvent(s) (0.05 M) at room temperature (RT = 25 °C).
2.0 equiv of the salt/base added.
Isolated yield after purification by column chromatography.
dr-diastereomeric ratio between exo and endo isomers, calculated based on the isolated product and 1H NMR analysis. Decomp: substrates decomposed into unverifiable mixture; nd-not determined. The reaction was scaled up to 0.5 g of -Trp--Trp DKP, and there was no reduction in the isolated yield.
a
Reaction conditions: -Trp--Trp DKP (100 mg, 268.51 μmol, 1.00 equiv), bromide (10, 14, 17–20) (537.02 μmol, 2.0 equiv) in acetic acid (0.05 M).
Isolated yield after purification by column chromatography.
dr and regioisomeric ratio calculated yield and 1H NMR analysis.
Mono- and dibenzylation ratio determined by 1H NMR analysis. RT = 25 °C.
Scheme 2Enantiospecific Access to C3/C2-Isoprenylated Trp Natural Products: Tryprostatin B, Drimentine C, and Nocardioazine B
Scheme 3Example of DMATS Prenylating Indole Core Regioselectivity
Figure 3(A) nOe correlations for cyclic C3-isoprenylated pyrroloindolines reported herein; (B) 1H–1H COSY data and nOe correlations for -Trp--Trp DKP reported in ref (9b).
Scheme 4Biomimetic Pathway Illustrating the Similarity of General-Acid–General-Base-Promoted C3-Isoprenylations